Glutarate

Glutarate

SCHEMBL104914

O=C([O-])CCCC(=O)[O-].[K+].[K+]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Glutarate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.58
HDAC3 O15379 3/20 0.50
HDAC1 Q13547 3/20 0.50
HDAC2 Q92769 3/20 0.50
HDAC8 Q9BY41 3/20 0.50
FFAR3 O14843 2/20 0.50
FABP3 P05413 7/20 0.46
BBOX1 O75936 3/20 0.46
CA4 P22748 1/20 0.44
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutarate SCHEMBL106584 0.96 CA1 (0.55) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL8745235 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL106537 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5650126 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL8618874 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5142628 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL2067310 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5650130 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL5142631 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL3142994 0.92 CA1 (0.58) CA1HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116669434-A Tin oxide electron transport layer modified in situ by aliphatic carboxylic acid potassium salt, high-performance photovoltaic cell and preparation method thereof 武汉理工大学 2023-08-29 CN claimed
CN-111185071-B Carbon dioxide absorbent and preparation method and application thereof 国家能源投资集团有限责任公司 2022-03-11 CN claimed
CN-108059376-B Preparation method of dental model gypsum 青岛大学附属医院 2020-12-08 CN claimed
CN-111185071-A Carbon dioxide absorbent and preparation method and application thereof 国家能源投资集团有限责任公司 2020-05-22 CN claimed
US-20200071262-A1 METHOD FOR PRODUCING ADIPAMIDE AS INTERMEDIATE FOR PRODUCTION OF RAW MATERIAL FOR BIO-BASED NYLON HYUNDAI MOTOR COMPANY (KR) 2020-03-05 US claimed
US-10508060-B1 Fertilizer with organic potassium salts Nachurs Alpine Solutions, Corp. (US) 2019-12-17 US claimed
US-20180258001-A1 Fertilizer for Salt-Sensitive Crops Nachurs Alpine Solutions, Corp. (US) 2018-09-13 US claimed
US-20180244589-A1 Fertilizer with Organic Potassium Salts Nachurs Alpine Solutions, Corp. (US) 2018-08-30 US claimed
CN-108147447-A A kind of liquid phase method prepares the processing technology of alpha semi-hydrated gypsum 应城市嘉鸿技术服务科技有限公司 2018-06-12 CN claimed
CN-108059376-A A kind of preparation method of dental models gypsum 应城市嘉鸿技术服务科技有限公司 2018-05-22 CN claimed
US-9034810-B2 Processing agent composition for semiconductor surface and method for processing semiconductor surface using same WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2015-05-19 US claimed
WO-2012143794-A1 POLYMER STABILIZER SYSTEM FOR POLYMERS CONTAINING HALOGEN GALATA CHEMICALS GMBH (DE) 2012-10-26 WO claimed
EP-2475000-A1 PROCESSING AGENT COMPOSITION FOR SEMICONDUCTOR SURFACE AND METHOD FOR PROCESSING SEMICONDUCTOR SURFACE USING SAME Wako Pure Chemical Industries, Ltd. (JP) 2012-07-11 EP claimed
US-20120157368-A1 PROCESSING AGENT COMPOSITION FOR SEMICONDUCTOR SURFACE AND METHOD FOR PROCESSING SEMICONDUCTOR SURFACE USING SAME WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-06-21 US claimed
WO-2009010464-A1 BEVERAGE WITH HIGH AMOUNT OF POTASSIUM UNILEVER N.V. (NL) 2009-01-22 WO claimed
US-20080260948-A1 INK AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2008-10-23 US claimed
EP-0164908-B1 PROCESS FOR PREPARATION OF COMPOSITIONS FOR MODIFYING PLANT GROWTH; COMPOSITION FOR PLANT GROWTH MODIFICATION: AND METHOD FOR THE USE THEREOF ACTAGRO, INC. (US) 1989-09-13 EP claimed
EP-0164908-A1 Process for preparation of compositions for modifying plant growth; composition for plant growth modification: and method for the use thereof ACTAGRO, INC. (US) 1985-12-18 EP claimed
US-4448702-A Freezing-point-lowering composition and method LANG & CO., CHEMISCH-TECHNISCHE PRODUKTE KOMMANDITGESELLSCHAFT (AT) 1984-05-15 US claimed
US-4200586-A Inhibiting the carbon-carbon double bond isomerization of substituted or unsubstituted hydrocarbon compounds PHILLIPS PETROLEUM COMPANY (US) 1980-04-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071262-A1 METHOD FOR PRODUCING ADIPAMIDE AS INTERMEDIATE FOR PRODUCTION OF RAW MATERIAL FOR BIO-BASED NYLON IDH2, HK2, SLC2A2 CA1 1451/4885HDAC3 725/4885HDAC1 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.